These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18989054)

  • 1. Update in management of coronary bifurcation lesions in the drug-eluting stent era.
    Sharma SK
    Indian Heart J; 2006; 58(2):108-19. PubMed ID: 18989054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary bifurcation lesions.
    Sharma SK; Mareş AM; Kini AS
    Minerva Cardioangiol; 2009 Oct; 57(5):667-82. PubMed ID: 19838156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of percutaneous therapy for bifurcation lesions in the era of drug-eluting stents.
    Pendyala L; Jabara R; Hou D; Shinke T; Li J; Gadesam R; Robinson K; Chronos N; Chen JP
    Minerva Cardioangiol; 2008 Feb; 56(1):89-105. PubMed ID: 18432172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches to ostial and bifurcation lesions.
    Hoye A; van der Giessen WJ
    J Interv Cardiol; 2004 Dec; 17(6):397-403. PubMed ID: 15546292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary bifurcation lesions: a current update.
    Sharma SK; Sweeny J; Kini AS
    Cardiol Clin; 2010 Feb; 28(1):55-70. PubMed ID: 19962049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
    Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
    Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in percutaneous management of coronary bifurcation lesions.
    Dzavik V
    Minerva Cardioangiol; 2005 Oct; 53(5):379-401. PubMed ID: 16179882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on dedicated bifurcation stents.
    Sheiban I; Omedé P; Biondi-Zoccai G; Moretti C; Sciuto F; Trevi GP
    J Interv Cardiol; 2009 Apr; 22(2):150-5. PubMed ID: 19379474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention of bifurcation coronary disease.
    Suzuki N; Angiolillo DJ; Kawaguchi R; Futamatsu H; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Feb; 55(1):57-71. PubMed ID: 17287681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of coronary bifurcation lesions].
    Romagnoli E; Clementi F; Biondi-Zoccai GG; Sangiorgi GM
    G Ital Cardiol (Rome); 2008 Oct; 9(10):690-705. PubMed ID: 18942557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel side branch ostial stent.
    Chen SL; Lv SZ; Kwan TW
    J Interv Cardiol; 2009 Apr; 22(2):145-9. PubMed ID: 19379473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifurcation stenting: current strategies and new devices.
    Latib A; Colombo A; Sangiorgi GM
    Heart; 2009 Mar; 95(6):495-504. PubMed ID: 18812408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex coronary interventions: unprotected left main and bifurcation lesions.
    Barlis P; Tanigawa J; Kaplan S; di Mario C
    J Interv Cardiol; 2006 Dec; 19(6):510-24. PubMed ID: 17107366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stent thrombosis after percutaneous coronary intervention for bifurcation lesions.
    Tan HC
    J Interv Cardiol; 2009 Apr; 22(2):114-6. PubMed ID: 19379468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of crush versus no crush technique for coronary artery bifurcation lesions.
    Gao Z; Yang YJ; Xu B; Chen JL; Qiao SB; Li JJ; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; Liu HB; Dai J; Gao RL
    Chin Med J (Engl); 2009 Mar; 122(6):627-31. PubMed ID: 19323924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel paclitaxel-eluting dedicated bifurcation stent: a case report from the first human use Taxus Petal trial.
    Johnson TW; Kay IP; Ormiston JA
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):637-40. PubMed ID: 19213074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery bifurcation lesions: a review and update on classification and interventional techniques.
    Movahed MR; Kern K; Thai H; Ebrahimi R; Friedman M; Slepian M
    Cardiovasc Revasc Med; 2008; 9(4):263-8. PubMed ID: 18928952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A; Brodsky A; Sabapathy R; Pershad A
    Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of drug-eluting stents in venous coronary artery bypass grafts.
    Hernandez-Antolín R; Alfonso F; Jimenez P
    EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.